Drug Database
Back to search

United States· US:61958-2005_136e06f8-479d-4ecf-99f4-2a000ae61412

DESCOVY

A emtricitabine and tenofovir alafenamide product containing emtricitabine; tenofovir alafenamide fumarate, registered in United States by Gilead Sciences, Inc.. The same ATC class is registered in 13 of our 19 countries.

ATC J05AR17

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDESCOVYATCJ05AR17REGISTER NO.US:61958-2005_136e06f…PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about emtricitabine; tenofovir alafenamide fumarateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Emtricitabine and tenofovir alafenamide is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AR17 (emtricitabine and tenofovir alafenamide), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 8 of them publish a price we can compare per daily dose
Search emtricitabine and tenofovir alafenamide products by name

Emtricitabine and tenofovir alafenamide · ATC J05AR17

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
Manufacturer
Gilead Sciences, Inc.
Country
United States (US)
ATC code
J05AR17
ATC class
Emtricitabine and tenofovir alafenamide
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    61958-2005-1

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Emtricitabine and tenofovir alafenamide in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All emtricitabine and tenofovir alafenamide products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Czechia · Emtricitabine/Tenofovir Alafenamide Zentiva
  • Denmark · Emtricitabin/Tenofoviralafenamid Lupin, Emtricitabine/Tenofovir Alafenamide Medical Valley
  • Spain · Emtricitabina/Tenofovir Alafenamida Dr. Reddys, Emtricitabina/Tenofovir Alafenamida Zentiva
  • Finland · Emtricitabine/Tenofovir Alafenamide Lupin
  • France · Emtricitabine/Tenofovir Alafenamide Zentiva
  • United Kingdom (Northern Ireland) · Emtricitabine/Tenofovir Alafenamide Amarox, Emtricitabine/Tenofovir Alafenamide Zentiva Pharma
  • Iceland · Descovy, Emtricitabine/Tenofovir Alafenamide Viatris
  • Italy · Emtricitabina E Tenofovir Alafenamide Zentiva
  • Liechtenstein · Descovy, Emtricitabine/Tenofovir Alafenamide Viatris
  • Netherlands · Emtricitabine/Tenofovir Alafenamide Zentiva, Emtricitabine/Tenofoviralafenamide Lupin
  • Norway · Descovy, Emtricitabine/ Tenofovir Alafenamide Lupin
  • Portugal · Emtricitabina + Tenofovir Alafenamida Zentiva
  • Sweden · Emtricitabine/ Tenofovir Alafenamide Lupin, Emtricitabine/Tenofovir Alafenamide Zentiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/97bc5923-65d3-4f21-9c57-c548ad7939f7
GET /v1/drugs/97bc5923-65d3-4f21-9c57-c548ad7939f7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "120; 15",
  "substance": "EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE",
  "productndc": "61958-2005",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1; mg/1",
  "application_number": "NDA208215",
  "marketing_category": "NDA"
}
API referenceMCP serverPlans

See everything about emtricitabine and tenofovir alafenamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console